UK markets closed

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
73.01-1.61 (-2.15%)
As of 2:51PM EST. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Cash flows from operating activities
Net income
7,067,000
7,067,000
9,843,000
6,220,000
2,394,000
Depreciation & amortisation
-
-
3,652,000
4,519,000
4,637,000
Deferred income taxes
-
-
-556,000
-509,000
-2,621,000
Stock-based compensation
-
-
417,000
348,000
312,000
Change in working capital
-
-
-2,067,000
-1,553,000
-5,021,000
Accounts receivable
-
-
294,000
-418,000
297,000
Inventory
-
-
-508,000
-911,000
-145,000
Accounts payable
-
-
399,000
230,000
254,000
Other working capital
-
-
9,967,000
8,307,000
4,559,000
Other non-cash items
-
-
1,177,000
1,628,000
769,000
Net cash provided by operating activities
-
-
13,440,000
10,922,000
6,447,000
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-3,473,000
-2,615,000
-1,888,000
Acquisitions, net
-
-
-4,954,000
-431,000
-396,000
Purchases of investments
-
-
-3,202,000
-7,994,000
-10,739,000
Sales/maturities of investments
-
-
8,622,000
15,252,000
15,664,000
Other investing activities
-
-
378,000
102,000
38,000
Net cash used for investing activities
-
-
-2,629,000
4,314,000
2,679,000
Cash flows from financing activities
Debt repayment
-
-
0
-4,287,000
-1,103,000
Common stock repurchased
-
-
-4,780,000
-9,091,000
-4,014,000
Dividends paid
-
-
-5,695,000
-5,172,000
-5,167,000
Other financing activities
-
-
5,000
-325,000
-195,000
Net cash used provided by (used for) financing activities
-
-
-8,861,000
-13,160,000
-10,006,000
Net change in cash
-
-
1,967,000
1,871,000
-423,000
Cash at beginning of period
-
-
7,967,000
6,096,000
6,515,000
Cash at end of period
-
-
9,934,000
7,967,000
6,092,000
Free cash flow
Operating cash flow
-
-
13,440,000
10,922,000
6,447,000
Capital expenditure
-
-
-3,473,000
-2,615,000
-1,888,000
Free cash flow
-
-
9,967,000
8,307,000
4,559,000